G20 Global Pharma Summit Series-Indonesia

AI has been able to accurately categorise lung cancer subtypes by analysis of digital pathological tissue sections in lung cancer histological diagnosis and can predict the survival prognosis of NSCLC patients.  The use of AI in the diagnosis of CRC. The use of AI in CRC screening can increase the rate of early detection and hence considerably lower the incidence and mortality of CRC patients. AI-enabled bioinformatics techniques can aid in the screening and identification of additional CRC biomarkers.